Sigma Pharmaceuticals

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Sigma Pharmaceuticals Limited
Type Public company (ASX:SIP)
Industry Pharmaceuticals
Founded 1912 in Melbourne, Australia
Headquarters Rowville, Victoria, Australia
Area served Worldwide
Key people Brian Jamieson (Chairman)
Mark Hooper (CEO & managing director)
Products Prescription, Over-the-counter and Generic Pharmaceutical Products
Revenue A$2.9 billion
Employees 850
Subsidiaries Amcal
Amcal Max
Guardian Pharmacies
Website sigmaco.com.au

Sigma Pharmaceuticals Limited is a leading full line wholesale and distribution business to pharmacy. It is also the owner of two of Australia's best known pharmacy retail brands: Amcal Max, Amcal and Guardian.

2010 trading halt[edit]

In 2010, Sigma shares were placed in a trading halt on the Australian Stock Exchange – initially due to a profit warning. Since then, allegations of accounting irregularities[1] and preferential deals negotiated with certain pharmacy chains (at the expense of smaller independent chemists) that left Sigma losing money at the expense of their own Amcal and Guardian Pharmacies banners[2] and forsaking cashflow have emerged.[3] The trading halt was lifted later that year. These events resulted in the initiation of a shareholder class action, which is before the Federal Court of Australia.

References[edit]

External links[edit]